Maureen Smythe, Pharm.D.

Maureen Smythe, Pharm.D.

Professor (Clinical)

Office Location

EACPHS, Room 4126

Phone

313-577-5384

Email

msmythe@beaumont.edu

Department

Pharmacy Practice

Research website

https://orcid.org/0000-0002-5978-3770

Maureen Smythe, Pharm.D.

Degrees and Certifications

  • 1988 - Critical Care Fellowship, Wayne State University
  • 1988 - Pharm.D., Wayne State University
  • 1986 - B.S. Pharmacy, Wayne State University

Positions and Employment

  • 2017-present - Clinical Pharmacy Specialist- Anticoagulation, Beaumont
  • 2001-present - Professor of Pharmacy (Clinical)
  • 1988-present - Coordinator of Student Experiential Training at Beaumont
  • 2006 – 2017 - Director PGY1 Residency Program at Beaumont

Awards and Honors

  • 2017 - Wayne State University Distinguished Alumni Award
  • 2016 - Preceptor of Student Community Research Award
  • 2016 - WSU Student Research Awards
  • 2012 - Outstanding Achievement in Clinical Sciences Research, Wayne State University
  • 2007 - Preceptor of the Year, William Beaumont Hospital
  • 2005 - Teacher of the Year, Wayne State University, Professional 3rd year class
  • 2004 - Teacher of the Year, Wayne State University, Professional 3rd year class

Professional Memberships

  • American College of Clinical Pharmacy
  • Society of Critical Care Medicine through 2012
  • American Society of Health-System Pharmacists
  • Southeastern Michigan Society of Health-System Pharmacists

Areas of Expertise

  • Anticoagulation
  • Critical care therapeutics

Primary Research Interest

  • Anticoagulation management
  • Thrombosis
  • Critical care therapeutics

Recent Publications

Refereed Journals

  • Smythe MA, Koerber JM, Roberts AM, Hoffman JL, Batke J. Hospital acquired venous thromboembolism, a preventability assessment, Hosp Pharm 2024; 59 (2):183-187.
  • Smythe MA, Wu W, Garwood C. Anticoagulant Drug-Drug Interactions with Cannabinoids: A Systematic Review, Pharmacother 2023; 43 (12):1327-1338.
  • Smythe MA, Burns C, Liu Q, Garwood CL. Potential dexamethasone-direct oral anticoagulant drug interaction, is this a concern in COVID? Ann Pharmacother 2022; 56 (3):319-329
  • Smythe MA, Hoffman JL, Koerber JM, Mertz S, Fritsch K, Chehab F et al. Outcomes of activated prothrombin complex concentrate for direct Xa inhibitor bleeding; Thrombosis Research 2021; 206 142-144

Non refereed abstracts

  • Nguyen VX*, Pechenko E, Koerber J, Hoffman J, Smythe MA. Evaluation of the efficacy and safety of 4-Factor Prothrombin Complex Concentrate in the Reversal of Apixaban and Rivaroxaban Acute Bleeding, presentation at the ASHP Midyear Clinical Meeting, Anaheim, CA, December 2023 (*presenting author)

Abstracts

  • Smythe M, Koerber J, Fodera A, Hoffman J, Batke J. Hospital Acquired Venous Thromboembolism: A Preventability Assessment, JACCP 2023;6(7):792 (#77).

 

Courses taught by Maureen Smythe, Pharm.D.

Fall Term 2024

Fall Term 2023

Fall Term 2022

← Return to listing